DE60223176D1 - Metallkomplexverbindungen - Google Patents

Metallkomplexverbindungen

Info

Publication number
DE60223176D1
DE60223176D1 DE60223176T DE60223176T DE60223176D1 DE 60223176 D1 DE60223176 D1 DE 60223176D1 DE 60223176 T DE60223176 T DE 60223176T DE 60223176 T DE60223176 T DE 60223176T DE 60223176 D1 DE60223176 D1 DE 60223176D1
Authority
DE
Germany
Prior art keywords
metal complex
complex compounds
vivo
nmr
mri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60223176T
Other languages
English (en)
Other versions
DE60223176T2 (de
Inventor
Jo Klaveness
Pal Rongved
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare AS filed Critical GE Healthcare AS
Publication of DE60223176D1 publication Critical patent/DE60223176D1/de
Application granted granted Critical
Publication of DE60223176T2 publication Critical patent/DE60223176T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DE60223176T 2001-11-28 2002-11-28 Metallkomplexverbindungen Expired - Lifetime DE60223176T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20015814 2001-11-28
NO20015814A NO20015814D0 (no) 2001-11-28 2001-11-28 Metallkompleksforbindelser
PCT/NO2002/000453 WO2003045442A1 (en) 2001-11-28 2002-11-28 Metal complex compounds

Publications (2)

Publication Number Publication Date
DE60223176D1 true DE60223176D1 (de) 2007-12-06
DE60223176T2 DE60223176T2 (de) 2008-08-07

Family

ID=19913076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60223176T Expired - Lifetime DE60223176T2 (de) 2001-11-28 2002-11-28 Metallkomplexverbindungen

Country Status (7)

Country Link
US (1) US7198776B2 (de)
EP (1) EP1465669B1 (de)
AT (1) ATE376428T1 (de)
AU (1) AU2002365365A1 (de)
DE (1) DE60223176T2 (de)
NO (1) NO20015814D0 (de)
WO (1) WO2003045442A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
DE60336754D1 (de) * 2002-02-14 2011-05-26 Univ R Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) * 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
CA2487247A1 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
EP1563300B1 (de) 2002-11-20 2012-04-18 The Board Of Trustees Of The Leland Stanford Junior University Diagnoseverfahren für sprue/zöliakie
US7640052B2 (en) 2004-05-28 2009-12-29 Ippp, Llc Method of integrated proton beam and therapeutic magnetic resonance therapy
US7801585B1 (en) 2003-06-02 2010-09-21 Newlife Sciences Llc System for analyzing and treating abnormality of human and animal tissues
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7628985B2 (en) * 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US8108047B2 (en) 2005-11-08 2012-01-31 Newlife Sciences Llc Device and method for the treatment of pain with electrical energy
US20080109049A1 (en) * 2006-11-08 2008-05-08 Schumann Daniel H Device & method for relieving pain
US8778338B2 (en) * 2007-03-16 2014-07-15 The Board Of Trustees Of The Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
GB0708411D0 (en) * 2007-05-01 2007-06-06 Univ Durham Lanthanide probes
US20090149732A1 (en) * 2007-12-08 2009-06-11 Weinstock Ronald J System for use of electrical resonant frequencies in analyzing and treating abnormality of human and animal tissues
US20100324627A1 (en) * 2008-07-28 2010-12-23 Newlife Sciences, Llc Method and apparatus for resistivity measurement, detection and treatment in living tissue
US20110217241A1 (en) * 2008-11-14 2011-09-08 University Of Maryland, Baltimore Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
JP5944918B2 (ja) 2010-11-30 2016-07-05 ニューライフ サイエンシーズ エルエルシー 身体インピーダンスアナライザによる疼痛治療装置および方法
EP3942067A4 (de) 2019-02-15 2022-11-23 Illumina, Inc. Messsysteme
JP2022537947A (ja) 2019-06-12 2022-08-31 トゥルーリリーフ エルエルシー パルス電流を生体組織に送達するためのシステムおよび方法
US11911605B2 (en) 2021-03-05 2024-02-27 Truerelief Llc Method and apparatus for injury treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
US5707605A (en) 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5980862A (en) 1995-06-02 1999-11-09 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
DE19603033A1 (de) 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
EP1032430A2 (de) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Mri-mittel zum nachweis von physiologischen mitteln

Also Published As

Publication number Publication date
NO20015814D0 (no) 2001-11-28
AU2002365365A1 (en) 2003-06-10
ATE376428T1 (de) 2007-11-15
WO2003045442A1 (en) 2003-06-05
US20050090653A1 (en) 2005-04-28
EP1465669A1 (de) 2004-10-13
DE60223176T2 (de) 2008-08-07
US7198776B2 (en) 2007-04-03
EP1465669B1 (de) 2007-10-24

Similar Documents

Publication Publication Date Title
DE60223176D1 (de) Metallkomplexverbindungen
DK1472541T3 (da) Afbildningsmidler og metoder til at afbilde NAALADase og PSMA
DK1419154T3 (da) Rapamycin-29-enoler
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
WO2002044156A3 (en) Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
DE602004027600D1 (de) Genexpressionsmarker für die prognose von brustkrebs
HUP0301835A2 (hu) Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva
NO991688D0 (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
MX2007013834A (es) Terapias de enfermedades vasculares.
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
GB2388190B (en) Methods for measuring enzyme activity
DE60032784D1 (de) Markerproteine für prostatakrebs
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
NO20025124D0 (no) Metode
PT1604211E (pt) Identificação de compostos terapêuticos
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE337020T1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
ATE281455T1 (de) Oxindolderivate
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
SE0202608D0 (sv) New sequences
WO2008014296A3 (en) Composition and method for treatment of tumors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1465669

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB